The mechanistic basis and the functional consequences of the repression of FGFR-induced nuclear ERK activation by activated SMO merit further in-depth investigation, as this regulatory network affects key genes such as c-MYC and MYCN, both relevant for MB tumor initiation and progression of different MB subtypes [2]. This evidence concerns the gene MYCN and neoplasm.